Sirolimus lowers myeloperoxidase and p-ANCA titers in a pediatric patient before kidney transplantation

American Journal of Kidney Diseases

Volumn 40, Issue 2, 2002, Pages 407-410

  Constantinescu, Alex R ^a   Liang, Michael ^a   Laskow, David A ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Microscopic polyangiitis; p ANCA vasculitis; Pediatric kidney transplantation; Sirolimus

Indexed keywords

MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RAPAMYCIN;

ADOLESCENT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PREOPERATIVE TREATMENT; SYSTEMIC VASCULITIS; TREATMENT OUTCOME;

EID: 0036324991     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.34544     Document Type: Article

References (20)

1. Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: Update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vascultitis after kidney transplantation
2. Anti-myeloperoxidase autoantibodies in patients with necrotizing glomerular and alveolar capillaritis
3. Renal transplantation for uncommon diseases
4. Successful renal transplantation in Wegener's granulomatosis
5. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomized multicenter study
6. Effect of in vivo rapamycin on de novo T-cell development in relation to induction of autoimmune-like immunopathology in the rat
7. Recurrent ANCA-associated small vessel vasculitis after transplantation: A pooled analysis
8. Renal transplantation in patients with microscopic polyarteritis and antimyeloperoxidase antibodies: Report of three cases
9. Outcome of patients with antineutrophil cytoplasmic antibody-associated vasculitis following cadaveric kidney transplantation
10. Necrotizing glomerulonephritis associated with antimyeloperoxidase antibodies in a renal transplant recipient with renal failure of unknown origin
11. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis
12. Renal transplantation in Wegener's granulomatosis
13. Clinical course of patients with antineutrophil cytoplasm antibody positive vasculitis after kidney transplantation
14. Systemic vasculitis in a kidney transplant population
15. De novo systemic vasculitis in a renal transplant recipient
16. De novo ANCA-associated vasculitis occurring 14 years after kidney transplantation
17. Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry (RADR)
18. Effects of rapamycin in experimental organ allografting
19. RAPT1, a mammalian homologue of yeast Tor, interacts with the FKBP12/rapamycin complex
20. Rapamycin inhibits production of cytotoxic but not non-cytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats